Opinion
Video
Author(s):
Panelists discuss how atopic dermatitis impacts different demographic groups through variations in disease presentation, treatment access, and quality of life outcomes.
Limited Evidence Supporting the Efficacy of Antifungals for Atopic Dermatitis
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Nutrition, Obesity, and Anxiety Can Impact the Severity of Seborrheic Dermatitis
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Nektar Therapeutics Completes Enrollment for Phase 2b REZOLVE-AD Trial of Rezpegaldesleukin
Ruxolitinib Cream Shows Strong Efficacy in Max-Use Pediatric Trial